Pegasys peginterferon regulatory update

ROCZ submitted an MAA to the EMEA for Pegasys peginterferon alfa-2a to treat chronic HBV infection, as well as an sBLA to FDA for the compound to treat chronic HBV infection. Pegasys is marketed in th...